سعر سيليستاركش 2.5مجم/5مل شراب 120مل 2022

Desloratadine 2.5 mg/5 ml oral syrup, 120 ml bottle (Alpac / EGPI), second-generation antihistamine.

• Seasonal allergic rhinitis: relief of nasal and non-nasal symptoms (patients 2 years and older).Population: Patients 2 years and olderDailyMed (U.S. National Library of Medicine)
• Perennial allergic rhinitis: relief of nasal and non-nasal symptoms (patients 6 months and older).Population: Patients 6 months and olderDailyMed (U.S. National Library of Medicine)
• Chronic idiopathic urticaria: symptomatic relief of pruritus and reduction in the number and size of hives (patients 6 months and older).Population: Patients 6 months and olderDailyMed (U.S. National Library of Medicine)

• Paediatric trials (6 months-11 years) reported upper respiratory tract infections, diarrhoea, fever, irritability, coughing, somnolence, bronchitis, otitis media, vomiting and others; in adults/adolescents the most common were pharyngitis, dry mouth, myalgia, fatigue, somnolence and dysmenorrhoea.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Hypersensitivity to desloratadine, to any ingredient of the product, or to loratadine.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Hypersensitivity reactions including rash, pruritus, urticaria, oedema, dyspnoea and anaphylaxis have been reported; discontinue if they occur.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Erythromycin, ketoconazole (CYP3A4 inhibitors)Increased plasma concentrations of desloratadine and 3-hydroxydesloratadine were observed with co-administration, without clinically relevant changes in the safety profile.DailyMed (U.S. National Library of Medicine)

• The limited available data with desloratadine in pregnant women are not sufficient to inform a drug-associated risk for major birth defects and miscarriage.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Desloratadine passes into breast milk; weigh the benefits of breastfeeding against the clinical need for the drug and possible effects on the infant.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Desloratadine: Long-acting tricyclic histamine antagonist with selective H1-receptor antagonist activity; the major active metabolite of loratadine.